SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-06-103181
Filing Date
2006-05-08
Accepted
2006-05-08 13:28:47
Documents
5
Period of Report
2006-05-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 21812
2 JOINT PRESS RELEASE dex991.htm EX-99.1 11242
3 PRESS RELEASE dex992.htm EX-99.2 12754
4 PRESS RELEASE dex993.htm EX-99.3 197941
5 GRAPHIC g90705image.jpg GRAPHIC 26134
  Complete submission text file 0001193125-06-103181.txt   281790
Mailing Address 345 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 345 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650.635.1100
Monogram Biosciences, Inc. (Filer) CIK: 0001094961 (see all company filings)

IRS No.: 943234479 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30369 | Film No.: 06815914
SIC: 2835 In Vitro & In Vivo Diagnostic Substances